Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants. [PDF]
Arq Bras Oftalmol, 2023 Moreno-López M +5 more
europepmc +1 more source
Cystoid Macular Edema Arising 10 Years After Cessation of Pentosan Polysulfate Sodium Successfully Treated With Bevacizumab. [PDF]
J Vitreoretin Dis, 2023 Szelog JT, Shah NS, Camejo MD.
europepmc +1 more source
Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review. [PDF]
J Vitreoretin Dis, 2023 Wang P +5 more
europepmc +1 more source
Predictive value of the characteristics of intraretinal cystoid spaces on early response to antivascular endothelial growth factor treatment in patients with cystoid diabetic macular edema. [PDF]
Arq Bras Oftalmol, 2022 Karahan E +3 more
europepmc +1 more source
Retinoschisis in Coats Disease: Clinical Picture, Therapeutic Considerations, and Management Outcomes. [PDF]
J Vitreoretin Dis, 2021 Scott NL +5 more
europepmc +1 more source
Aflibercept for Radiation Maculopathy (ARM Study): Year-2 Extension of a Prospective Clinical Study. [PDF]
J Vitreoretin Dis, 2021 Murray TG +3 more
europepmc +1 more source
Treatment of non-infectious retinal vasculitis. [PDF]
Ther Adv Ophthalmol, 2023 Rivera PA, Gupta A, Kombo N.
europepmc +1 more source
Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments. [PDF]
Ther Adv Ophthalmol, 2021 Hussain RM +6 more
europepmc +1 more source
Successful Treatment of Full-Thickness Macular Hole in Polypoidal Choroidal Vasculopathy with Anti-VEGF Therapy. [PDF]
J Vitreoretin Dis, 2020 Lindeke-Myers A +3 more
europepmc +1 more source
A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology. [PDF]
Ther Adv Ophthalmol, 2022 Hasan N +5 more
europepmc +1 more source